|Other Names||CUB domain-containing protein 1, Membrane glycoprotein gp140, Subtractive immunization M plus HEp3-associated 135 kDa protein, SIMA135, Transmembrane and associated with src kinases, CD318, CDCP1, TRASK|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||May be involved in cell adhesion and cell matrix association. May play a role in the regulation of anchorage versus migration or proliferation versus differentiation via its phosphorylation. May be a novel marker for leukemia diagnosis and for immature hematopoietic stem cell subsets. Belongs to the tetraspanin web involved in tumor progression and metastasis.|
|Cellular Location||Isoform 1: Cell membrane; Single-pass membrane protein. Note=Shedding may also lead to a soluble peptide|
|Tissue Location||Highly expressed in mitotic cells with low expression during interphase. Detected at highest levels in skeletal muscle and colon with lower levels in kidney, small intestine, placenta and lung. Up-regulated in a number of human tumor cell lines, as well as in colorectal cancer, breast carcinoma and lung cancer. Also expressed in cells with phenotypes reminiscent of mesenchymal stem cells and neural stem cells|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
CDCP1 is a transmembraneprotein containing three extracellular CUB domains. This protein isfound to be overexpressed in colon and lung cancers. Its expressionlevel is correlated with the metastatic ability of carcinoma cells.This protein is located on the cell surface. It has been shown tobe tyrosine phosphorylated in a cancer cell line. Alternativelyspliced transcript variants encoding distinct isoforms have beenreported.
He, Y., et al. J. Biol. Chem. 285(34):26162-26173(2010)Miyazawa, Y., et al. Cancer Res. 70(12):5136-5146(2010)Mamat, S., et al. Oncol. Rep. 23(5):1221-1227(2010)Fukuchi, K., et al. Mol. Pharm. 7(1):245-253(2010)Deryugina, E.I., et al. Mol. Cancer Res. 7(8):1197-1211(2009)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.